Hepatera completed patient recruitment for clinical trials of an innovative drug against Hepatitis B with Delta Agent
Hepatera LLC, a biotechnology company of Maxwell Biotech Group and a resident of the Skolkovo Foundation Biomed Cluster, has completed the patient recruitment f...